KINEPS THERAPY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
KINEPS THERAPY
Largest movements
- Cash +€31,092
up €31,092 (+745%), from €4,173 to €35,265
mainly Other debts (+€32,569) and Net result for the year (+€22,032)
- Tangible fixed assets -€3,267
down €3,267 (-41.0%), from €7,969 to €4,702
- Deferred charges and accrued income -€1,392
down €1,392 (-22.6%), from €6,163 to €4,771
- Other debts +€32,569
up €32,569 (+1,004%), from €3,245 to €35,814
- Profit (loss) carried forward -€11,050
no longer reported in 2025 (was €11,050)
- Tax, wage and social debts +€4,768
up €4,768 (+236%), from €2,020 to €6,788
- Gross operating margin +€33,544
up €33,544 (+4,528%), from €741 to €34,285
- Taxes +€6,788
new in 2025: €6,788
- Financial charges -€558
down €558 (-22.2%), from €2,518 to €1,960
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €18,668 | €45,102 | +€26,433 | +142% |
| Fixed assets | 21/28 | €8,332 | €5,065 | -€3,267 | -39.2% |
| Tangible fixed assets | 22/27 | €7,969 | €4,702 | -€3,267 | -41.0% |
| Furniture and vehicles | 24 | €7,969 | €4,702 | -€3,267 | -41.0% |
| Financial fixed assets | 28 | €363 | €363 | = | 0.0% |
| Current assets | 29/58 | €10,336 | €40,037 | +€29,700 | +287% |
| Cash at bank and in hand | 54/58 | €4,173 | €35,265 | +€31,092 | +745% |
| Deferred charges and accrued income | 490/1 | €6,163 | €4,771 | -€1,392 | -22.6% |
| Total equity and liabilities | 10/49 | €18,668 | €45,102 | +€26,433 | +142% |
| Equity | 10/15 | €13,050 | €2,000 | -€11,050 | -84.7% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11,050 | - | -€11,050 | |
| Amounts payable | 17/49 | €5,618 | €43,102 | +€37,483 | +667% |
| Amounts payable within one year | 42/48 | €5,278 | €42,602 | +€37,323 | +707% |
| Trade debts | 44 | €13 | - | -€13 | |
| Suppliers | 440/4 | €13 | - | -€13 | |
| Taxes, remuneration and social security | 45 | €2,020 | €6,788 | +€4,768 | +236% |
| Taxes | 450/3 | €2,020 | €6,788 | +€4,768 | +236% |
| Other amounts payable | 47/48 | €3,245 | €35,814 | +€32,569 | +1,004% |
| Accrued charges and deferred income | 492/3 | €340 | €500 | +€160 | +47.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,267 | €3,267 | = | 0.0% |
| Other operating charges | 640/8 | €231 | €239 | +€8 | +3.3% |
| Gross operating margin | 9900 | €741 | €34,285 | +€33,544 | +4,528% |
| Operating profit (loss) | 9901 | -€2,757 | €30,779 | +€33,536 | |
| Financial charges | 65/66B | €2,518 | €1,960 | -€558 | -22.2% |
| Recurring financial charges | 65 | €2,518 | €1,960 | -€558 | -22.2% |
| Profit (loss) for the period before taxes | 9903 | -€5,274 | €28,819 | +€34,094 | |
| Income taxes | 67/77 | - | €6,788 | +€6,788 | |
| Profit (loss) for the period | 9904 | -€5,274 | €22,032 | +€27,306 | |
| Profit (loss) for the period to be appropriated | 9905 | -€5,274 | €22,032 | +€27,306 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.